Literature DB >> 9731924

Comparison of the Quality of Well-being Scale and the SF-36 results among two samples of ill adults: AIDS and other illnesses.

J P Anderson1, R M Kaplan, S J Coons, L J Schneiderman.   

Abstract

PURPOSE: To compare results of using the SF-36 Short Form 36 (SF-36) and the Quality of Well-being Scale (QWB) in characterizing health outcomes over time in patients having serious illnesses, including cancer and AIDS.
BACKGROUND: The SF-36 and the QWB are alternative measures of health-related quality of life. The SF-36 is a morbidity measure that features a profile of nine dimensions. The QWB is a preference-based measure that combines morbidity and mortality into a single number. However, the QWB can also be scored and used as a profile. We compare SF-36 and QWB scores with different scoring methods to assess validity and sensitivity to change over time in health outcomes for adult patients with HIV infection, cancer, and other serious illnesses.
SUBJECTS: 201 adults with serious illnesses, including 99 with AIDS and 102 with cancer or other illnesses. PROCEDURE: All subjects received both measures at baseline and at 6-month intervals thereafter, over a period of 21/2 years.
RESULTS: In the profile mode, the QWB captured outcomes that characterize the AIDS syndrome. The SF-36 differentiated between the AIDS and other illnesses patients on some scales, but without consistent direction. However, the overall QWB showed a decrease in quality of life over time for both the AIDS and other illnesses patients while the SF-36 did not. This is because many patients died and these were counted as outcomes by the QWB and as missing data by the SF-36.
CONCLUSIONS: The QWB appears to be better able to capture outcomes of serious illness over time than does the SF-36.

Entities:  

Mesh:

Year:  1998        PMID: 9731924     DOI: 10.1016/s0895-4356(98)00046-8

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  17 in total

1.  Simulated effect of tobacco tax variation on population health in California.

Authors:  R M Kaplan; C F Ake; S L Emery; A M Navarro
Journal:  Am J Public Health       Date:  2001-02       Impact factor: 9.308

2.  Estimation and comparison of derived preference scores from the SF-36 in lung transplant patients.

Authors:  Francis S Lobo; Cynthia R Gross; Barbara J Matthees
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

3.  [Self-perception of health in non-institutionalised elderly].

Authors:  M Meléndez Hernández; R Montero Herrero; C Jiménez Sánchez; L Blanco Montagut
Journal:  Aten Primaria       Date:  2001-06-30       Impact factor: 1.137

4.  Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS.

Authors:  Knut Stavem; Stig S Frøland; Kjell B Hellum
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

5.  The effect of diagnosis with HIV infection on health-related quality of Life.

Authors:  Shyoko Honiden; Vandana Sundaram; Robert F Nease; Mark Holodniy; Laura C Lazzeroni; Andrew Zolopa; Douglas K Owens
Journal:  Qual Life Res       Date:  2006-02       Impact factor: 4.147

Review 6.  A comparative review of health-related quality-of-life measures for use in HIV/AIDS clinical trials.

Authors:  Darren J Clayson; Diane J Wild; Paul Quarterman; Isabelle Duprat-Lomon; Maria Kubin; Stephen Joel Coons
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

7.  Comparing SF-36 scores across three groups of women with different health profiles.

Authors:  Kathleen J Yost; Mary N Haan; Richard A Levine; Ellen B Gold
Journal:  Qual Life Res       Date:  2005-06       Impact factor: 4.147

8.  Comorbidity of chronic diseases: effects of disease pairs on physical and mental functioning.

Authors:  Mieke Rijken; Marion van Kerkhof; Joost Dekker; François G Schellevis
Journal:  Qual Life Res       Date:  2005-02       Impact factor: 4.147

9.  Improved health-related quality of life after lung volume reduction surgery and pulmonary rehabilitation.

Authors:  Janna Beling
Journal:  Cardiopulm Phys Ther J       Date:  2009-09

10.  Quality of life of patients with Fabry disease.

Authors:  K F Gold; G M Pastores; M F Botteman; J M Yeh; S Sweeney; W Aliski; C L Pashos
Journal:  Qual Life Res       Date:  2002-06       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.